15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Itron Inc, 7 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $113.00 to $135.00, so the covering firms are broadly aligned. The average target of $127.71 sits 32% above the current $96.62. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.79 next quarter toward $6.92 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy778%
Hold222%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Itron Inc.
As of Sep, 7 of 9 firms rate ITRI a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ITRI EPS & revenue forecast
EPS · NEXT QUARTER
$1.79
Range $1.73 – $1.83 · 9 analysts · -27% YoY
Next period, 9 analysts expect Itron Inc to earn $1.79 a share (range $1.73 – $1.83), versus $2.46 a year earlier. Full-year consensus is $6.42, growing to $6.92 the year after.
REVENUE · NEXT QUARTER
$641.1M
Range $625.9M – $654.9M · 9 analysts · +12% YoY
Revenue is expected to reach $641.1M (range $625.9M – $654.9M), +12.1% year-over-year. Full-year consensus is $2.4B, rising to $2.5B next year.
Top analysts covering Itron Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ITRI.
#1
Tommy Moll
Stephens & Co. · Rank #56
Buy
$130.00+34.5% to target
Overall win rate
49%
+ Follow
#2
Noah Kaye
Oppenheimer · Rank #182
Buy
$135.00+39.7% to target
Overall win rate
40%
+ Follow
#3
Chip Moore
Roth MKM · Rank #302
Buy
$150.00+55.2% to target
Overall win rate
31%
+ Follow
#4
Ben Kallo
Baird · Rank #308
Buy
$125.00+29.4% to target
Overall win rate
29%
+ Follow
#5
Austin Moeller
Canaccord Genuity · Rank #318
Buy
$132.00+36.6% to target
Overall win rate
32%
+ Follow
ITRI stock forecast FAQ
What is ITRI's average 12-month price target?+
The 7 analysts with a live target average $127.71 for Itron Inc over the next 12 months, ranging from a $135.00 high to a $113.00 low.
Is ITRI stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 7 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ITRI?+
The Street-high target is $135.00 (Oppenheimer), and the Street-low is $113.00 (JP Morgan). The average of all 7 active targets is $127.71.
How many Wall Street analysts cover ITRI?+
9 analysts have an active rating on Itron Inc, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering ITRI?+
Among analysts who currently cover ITRI, Tommy Moll of Stephens & Co. has the strongest overall Quantellect track record (Rank #56). Their current call is Buy with a $130.00 target.
What is Itron Inc's projected EPS for next quarter?+
The consensus estimate is $1.79 per share (range $1.73 – $1.83) across 9 analysts. Full-year EPS is projected at $6.42, rising to $6.92 the following year.
How much revenue is Itron Inc expected to report next quarter?+
Consensus revenue is $641.1M (range $625.9M – $654.9M). Full-year revenue is projected at $2.4B, growing to $2.5B next year.
Have analysts been upgrading or downgrading ITRI lately?+
As of Sep, 7 of 9 firms rate ITRI a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ITRI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
